Skip to main content
Erschienen in: Inflammation 6/2022

02.07.2022 | Original Article

Aging Promotes Chronic Stress-Induced Depressive-Like Behavior by Activating NLRP1 Inflammasome-Driven Inflammatory Signaling in Mice

verfasst von: Ya-Jing Zhu, Jun-Juan Fan, Fang-Yi Wu, Ming Zhang, Ao-Qi Song, Yong Li, Yan-Kun Li, Wen-Ning Wu

Erschienen in: Inflammation | Ausgabe 6/2022

Einloggen, um Zugang zu erhalten

Abstract

NLRP1 inflammasome has been reported to participate in many neurological disorders. Our previous study has demonstrated that NLRP1 inflammasome is implicated in chronic stress-induced depressive-like behaviors in mice. Age has been reported to be related to depression. Here we examine whether NLRP1 inflammasome is involved in the effect of age on depressive disorder. Two chronic stress stimuli, chronic social defeat stress (CSDS) and repeat social defeat stress (RSDS), were used to establish a depression model in mice of different ages. We found that aged mice exhibited worse depressive-like behaviors and locomotor activity compared to young mice. Interestingly, the expression of hippocampal NLRP1 inflammasome complexes and the levels of the inflammatory cytokines were increased in an age-dependent manner. Also, chronic stress-induced increase in the expression of the hippocampal chemokine C-X-C motif ligand 1 (CXCL1), and its cognate receptor, CXC-motif receptor 2 (CXCR2), was more remarkable in aged mice than that in young mice. Moreover, aged mice exhibited lower hippocampal BDNF levels compared to young mice. Hippocampal Nlrp1a knockdown reduced the levels of pro-inflammatory cytokines and the expression of CXCL1/CXCR2, restored BDNF levels, and alleviated chronic stress-induced depressive-like behaviors in aged mice. Our results suggest that NLRP1 inflammasome-CXCL1/CXCR2-BDNF signaling contributes to the effect of age on chronic stress-induced depressive-like behavior in mice.
Literatur
1.
Zurück zum Zitat Ferrari, A.J., F.J. Charlson, R.E. Norman, S.B. Patten, G. Freedman, C.J. Murray, et al. 2013. Burden of depressive disorders by country, sex, age, and year: Findings from the global burden of disease study 2010. PLoS Medicine 10: e1001547.PubMedPubMedCentralCrossRef Ferrari, A.J., F.J. Charlson, R.E. Norman, S.B. Patten, G. Freedman, C.J. Murray, et al. 2013. Burden of depressive disorders by country, sex, age, and year: Findings from the global burden of disease study 2010. PLoS Medicine 10: e1001547.PubMedPubMedCentralCrossRef
2.
Zurück zum Zitat Consortium. C. 2015. Sparse whole-genome sequencing identifies two loci for major depressive disorder. Nature 523:588–91. Consortium. C. 2015. Sparse whole-genome sequencing identifies two loci for major depressive disorder. Nature 523:588–91.
3.
Zurück zum Zitat Zhang, J.C., W. Yao, and K. Hashimoto. 2016. Brain-derived neurotrophic factor (BDNF)-TrkB signaling in inflammation-related depression and potential therapeutic targets. Current Neuropharmacology 14: 721–731.PubMedPubMedCentralCrossRef Zhang, J.C., W. Yao, and K. Hashimoto. 2016. Brain-derived neurotrophic factor (BDNF)-TrkB signaling in inflammation-related depression and potential therapeutic targets. Current Neuropharmacology 14: 721–731.PubMedPubMedCentralCrossRef
4.
Zurück zum Zitat Geddes, J.R., and D.J. Miklowitz. 2013. Treatment of bipolar disorder. Lancet 381: 1672–1682.PubMedCrossRef Geddes, J.R., and D.J. Miklowitz. 2013. Treatment of bipolar disorder. Lancet 381: 1672–1682.PubMedCrossRef
5.
Zurück zum Zitat Duman, R.S., N. Li, R.J. Liu, V. Duric, and G. Aghajanian. 2012. Signaling pathways underlying the rapid antidepressant actions of ketamine. Neuropharmacology 62: 35–41.PubMedCrossRef Duman, R.S., N. Li, R.J. Liu, V. Duric, and G. Aghajanian. 2012. Signaling pathways underlying the rapid antidepressant actions of ketamine. Neuropharmacology 62: 35–41.PubMedCrossRef
6.
Zurück zum Zitat Kohler, O., J. Krogh, O. Mors, and M.E. Benros. 2016. Inflammation in depression and the potential for anti-inflammatory treatment. Current Neuropharmacology 14: 732–742.PubMedPubMedCentralCrossRef Kohler, O., J. Krogh, O. Mors, and M.E. Benros. 2016. Inflammation in depression and the potential for anti-inflammatory treatment. Current Neuropharmacology 14: 732–742.PubMedPubMedCentralCrossRef
7.
Zurück zum Zitat Howren, M.B., D.M. Lamkin, and J. Suls. 2009. Associations of depression with C-reactive protein, IL-1, and IL-6: A meta-analysis. Psychosomatic Medicine 71: 171–186.PubMedCrossRef Howren, M.B., D.M. Lamkin, and J. Suls. 2009. Associations of depression with C-reactive protein, IL-1, and IL-6: A meta-analysis. Psychosomatic Medicine 71: 171–186.PubMedCrossRef
8.
Zurück zum Zitat Haroon, E., C.L. Raison, and A.H. Miller. 2012. Psychoneuroimmunology meets neuropsychopharmacology: Translational implications of the impact of inflammation on behavior. Neuropsychopharmacol 37: 137–162.CrossRef Haroon, E., C.L. Raison, and A.H. Miller. 2012. Psychoneuroimmunology meets neuropsychopharmacology: Translational implications of the impact of inflammation on behavior. Neuropsychopharmacol 37: 137–162.CrossRef
9.
Zurück zum Zitat Miller, A.H., and C.L. Raison. 2016. The role of inflammation in depression: From evolutionary imperative to modern treatment target. Nature Reviews Immunology 16: 22–34.PubMedPubMedCentralCrossRef Miller, A.H., and C.L. Raison. 2016. The role of inflammation in depression: From evolutionary imperative to modern treatment target. Nature Reviews Immunology 16: 22–34.PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Mechawar, N., and J. Savitz. 2016. Neuropathology of mood disorders: do we see the stigmata of inflammation? Translational Psychiatry 6. Mechawar, N., and J. Savitz. 2016. Neuropathology of mood disorders: do we see the stigmata of inflammation? Translational Psychiatry 6.
11.
Zurück zum Zitat Dowlati, Y., N. Herrmann, W. Swardfager, H. Liu, L. Sham, E.K. Reim, et al. 2010. A meta-analysis of cytokines in major depression. Biological Psychiatry 67: 446–457.PubMedCrossRef Dowlati, Y., N. Herrmann, W. Swardfager, H. Liu, L. Sham, E.K. Reim, et al. 2010. A meta-analysis of cytokines in major depression. Biological Psychiatry 67: 446–457.PubMedCrossRef
12.
Zurück zum Zitat Hiles, S.A., A.L. Baker, T. de Malmanche, and J. Attia. 2012. A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: Exploring the causes of heterogeneity. Brain Behavior and Immunity 26: 1180–1188.PubMedCrossRef Hiles, S.A., A.L. Baker, T. de Malmanche, and J. Attia. 2012. A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: Exploring the causes of heterogeneity. Brain Behavior and Immunity 26: 1180–1188.PubMedCrossRef
13.
Zurück zum Zitat Yang, C.H., F.J. Bosker, J. Li, and R.A. Schoevers. 2018. N-acetylcysteine as add-on to antidepressant medication in therapy refractory major depressive disorder patients with increased inflammatory activity: study protocol of a double-blind randomized placebo-controlled trial. Bmc Psychiatry 18. Yang, C.H., F.J. Bosker, J. Li, and R.A. Schoevers. 2018. N-acetylcysteine as add-on to antidepressant medication in therapy refractory major depressive disorder patients with increased inflammatory activity: study protocol of a double-blind randomized placebo-controlled trial. Bmc Psychiatry 18.
14.
Zurück zum Zitat Rethorst, C.D., M.S. Toups, T.L. Greer, P.A. Nakonezny, T.J. Carmody, B.D. Grannemann, et al. 2013. Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder. Molecular Psychiatry 18: 1119–1124.PubMedCrossRef Rethorst, C.D., M.S. Toups, T.L. Greer, P.A. Nakonezny, T.J. Carmody, B.D. Grannemann, et al. 2013. Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder. Molecular Psychiatry 18: 1119–1124.PubMedCrossRef
15.
Zurück zum Zitat Tyring, S., A. Gottlieb, K. Papp, K. Gordon, C. Leonardi, A. Wang, et al. 2006. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: Double-blind placebo-controlled randomised phase III trial. Lancet 367: 29–35.PubMedCrossRef Tyring, S., A. Gottlieb, K. Papp, K. Gordon, C. Leonardi, A. Wang, et al. 2006. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: Double-blind placebo-controlled randomised phase III trial. Lancet 367: 29–35.PubMedCrossRef
17.
Zurück zum Zitat Brahadeeswaran, S., N. Sivagurunathan, and L. Calivarathan. 2022. Inflammasome signaling in the aging brain and age-related neurodegenerative diseases. Molecular Neurobiology 2022. Brahadeeswaran, S., N. Sivagurunathan, and L. Calivarathan. 2022. Inflammasome signaling in the aging brain and age-related neurodegenerative diseases. Molecular Neurobiology 2022.
18.
Zurück zum Zitat Calabrese, V., A. Santoro, D. Monti, R. Crupi, R. Di Paola, S. Latteri, et al. 2018. Aging and Parkinson’s disease: Inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis. Free Radical Biology & Medicine 115: 80–91.CrossRef Calabrese, V., A. Santoro, D. Monti, R. Crupi, R. Di Paola, S. Latteri, et al. 2018. Aging and Parkinson’s disease: Inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis. Free Radical Biology & Medicine 115: 80–91.CrossRef
19.
Zurück zum Zitat Cicolari, S., A.L. Catapano, and P. Magni. 2021. Inflammaging and neurodegenerative diseases: Role of NLRP3 inflammasome activation in brain atherosclerotic vascular disease. Mechanisms of Ageing and Development 195: 111467.PubMedCrossRef Cicolari, S., A.L. Catapano, and P. Magni. 2021. Inflammaging and neurodegenerative diseases: Role of NLRP3 inflammasome activation in brain atherosclerotic vascular disease. Mechanisms of Ageing and Development 195: 111467.PubMedCrossRef
20.
Zurück zum Zitat Franceschi, C., P. Garagnani, P. Parini, C. Giuliani, and A. Santoro. 2018. Inflammaging: A new immune-metabolic viewpoint for age-related diseases. Nature Reviews. Endocrinology 14: 576–590.PubMedCrossRef Franceschi, C., P. Garagnani, P. Parini, C. Giuliani, and A. Santoro. 2018. Inflammaging: A new immune-metabolic viewpoint for age-related diseases. Nature Reviews. Endocrinology 14: 576–590.PubMedCrossRef
21.
Zurück zum Zitat Guan, S., X. Fang, and X. Hu. 2014. Factors influencing the anxiety and depression of patients with dilated cardiomyopathy. International Journal of Clinical and Experimental Medicine 7: 5691–5695.PubMedPubMedCentral Guan, S., X. Fang, and X. Hu. 2014. Factors influencing the anxiety and depression of patients with dilated cardiomyopathy. International Journal of Clinical and Experimental Medicine 7: 5691–5695.PubMedPubMedCentral
22.
Zurück zum Zitat Latz, E., T.S. Xiao, and A. Stutz. 2013. Activation and regulation of the inflammasomes. Nature Reviews Immunology 13: 397–411.PubMedCrossRef Latz, E., T.S. Xiao, and A. Stutz. 2013. Activation and regulation of the inflammasomes. Nature Reviews Immunology 13: 397–411.PubMedCrossRef
23.
Zurück zum Zitat Chavarria-Smith, J., and R.E. Vance. 2015. The NLRP1 inflammasomes. Immunological Reviews 265: 22–34.PubMedCrossRef Chavarria-Smith, J., and R.E. Vance. 2015. The NLRP1 inflammasomes. Immunological Reviews 265: 22–34.PubMedCrossRef
24.
Zurück zum Zitat Golden, S.A., H.E. Covington 3rd., O. Berton, and S.J. Russo. 2011. A standardized protocol for repeated social defeat stress in mice. Nature Protocols 6: 1183–1191.PubMedPubMedCentralCrossRef Golden, S.A., H.E. Covington 3rd., O. Berton, and S.J. Russo. 2011. A standardized protocol for repeated social defeat stress in mice. Nature Protocols 6: 1183–1191.PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Golden, S.A., H.E. Covington 3rd., O. Berton, and S.J. Russo. 2015. Corrigendum: A standardized protocol for repeated social defeat stress in mice. Nature Protocols 10: 643.PubMedCrossRef Golden, S.A., H.E. Covington 3rd., O. Berton, and S.J. Russo. 2015. Corrigendum: A standardized protocol for repeated social defeat stress in mice. Nature Protocols 10: 643.PubMedCrossRef
26.
Zurück zum Zitat Eagle, A.L., C.E. Manning, E.S. Williams, R.M. Bastle, P.A. Gajewski, A. Garrison, et al. 2020. Circuit-specific hippocampal DeltaFosB underlies resilience to stress-induced social avoidance. Nature communications 11: 4484–4484.PubMedPubMedCentralCrossRef Eagle, A.L., C.E. Manning, E.S. Williams, R.M. Bastle, P.A. Gajewski, A. Garrison, et al. 2020. Circuit-specific hippocampal DeltaFosB underlies resilience to stress-induced social avoidance. Nature communications 11: 4484–4484.PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat McKim, D.B., M.D. Weber, A. Niraula, C.M. Sawicki, X. Liu, B.L. Jarrett, et al. 2018. Microglial recruitment of IL-1beta-producing monocytes to brain endothelium causes stress-induced anxiety. Molecular Psychiatry 23: 1421–1431.PubMedCrossRef McKim, D.B., M.D. Weber, A. Niraula, C.M. Sawicki, X. Liu, B.L. Jarrett, et al. 2018. Microglial recruitment of IL-1beta-producing monocytes to brain endothelium causes stress-induced anxiety. Molecular Psychiatry 23: 1421–1431.PubMedCrossRef
28.
Zurück zum Zitat Song, A.Q., B. Gao, J.J. Fan, Y.J. Zhu, J. Zhou, Y.L. Wang, et al. 2020. NLRP1 inflammasome contributes to chronic stress-induced depressive-like behaviors in mice. Journal of Neuroinflammation 17: 178.PubMedPubMedCentralCrossRef Song, A.Q., B. Gao, J.J. Fan, Y.J. Zhu, J. Zhou, Y.L. Wang, et al. 2020. NLRP1 inflammasome contributes to chronic stress-induced depressive-like behaviors in mice. Journal of Neuroinflammation 17: 178.PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat Walsh, C.M., R.Z. Hill, J. Schwendinger-Schreck, J. Deguine, E.C. Brock, N. Kucirek, et al. 2019. Neutrophils promote CXCR3-dependent itch in the development of atopic dermatitis. Elife 8. Walsh, C.M., R.Z. Hill, J. Schwendinger-Schreck, J. Deguine, E.C. Brock, N. Kucirek, et al. 2019. Neutrophils promote CXCR3-dependent itch in the development of atopic dermatitis. Elife 8.
31.
Zurück zum Zitat Seifert, B., R. Eckenstaler, R. Ronicke, J. Leschik, B. Lutz, K. Reymann, et al. 2016. Amyloid-beta induced changes in vesicular transport of BDNF in hippocampal neurons. Neural Plasticity 2016: 4145708.PubMedPubMedCentralCrossRef Seifert, B., R. Eckenstaler, R. Ronicke, J. Leschik, B. Lutz, K. Reymann, et al. 2016. Amyloid-beta induced changes in vesicular transport of BDNF in hippocampal neurons. Neural Plasticity 2016: 4145708.PubMedPubMedCentralCrossRef
32.
Zurück zum Zitat Chai, H.H., X.C. Fu, L. Ma, H.T. Sun, G.Z. Chen, M.Y. Song, et al. 2019. The chemokine CXCL1 and its receptor CXCR2 contribute to chronic stress-induced depression in mice. The FASEB Journal 33: 8853–8864.PubMedCrossRef Chai, H.H., X.C. Fu, L. Ma, H.T. Sun, G.Z. Chen, M.Y. Song, et al. 2019. The chemokine CXCL1 and its receptor CXCR2 contribute to chronic stress-induced depression in mice. The FASEB Journal 33: 8853–8864.PubMedCrossRef
34.
Zurück zum Zitat Kritsilis, M., S.V. Rizou, P.N. Koutsoudaki, K. Evangelou, V.G. Gorgoulis, and D. Papadopoulos. 2018. Ageing, cellular senescence and neurodegenerative disease. International Journal of Molecular Sciences 19. Kritsilis, M., S.V. Rizou, P.N. Koutsoudaki, K. Evangelou, V.G. Gorgoulis, and D. Papadopoulos. 2018. Ageing, cellular senescence and neurodegenerative disease. International Journal of Molecular Sciences 19.
35.
Zurück zum Zitat Alzheimer’s A. 2016. Alzheimer’s disease facts and figures. Alzheimer’s & Dementia 2016 (12): 459–509. Alzheimer’s A. 2016. Alzheimer’s disease facts and figures. Alzheimer’s & Dementia 2016 (12): 459–509.
36.
Zurück zum Zitat Floyd, R.A., and K. Hensley. 2002. Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases. Neurobiol Aging 23:795–807. Floyd, R.A., and K. Hensley. 2002. Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases. Neurobiol Aging 23:795–807.
37.
Zurück zum Zitat Navarro, A., and A. Boveris. 2008. Mitochondrial nitric oxide synthase, mitochondrial brain dysfunction in aging, and mitochondria-targeted antioxidants. Advanced Drug Delivery Reviews 60: 1534–1544.PubMedCrossRef Navarro, A., and A. Boveris. 2008. Mitochondrial nitric oxide synthase, mitochondrial brain dysfunction in aging, and mitochondria-targeted antioxidants. Advanced Drug Delivery Reviews 60: 1534–1544.PubMedCrossRef
38.
Zurück zum Zitat Maes, M., M. Berk, L. Goehler, C. Song, G. Anderson, P. Galecki, et al. 2012. Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. BMC Medicine 10: 66.PubMedPubMedCentralCrossRef Maes, M., M. Berk, L. Goehler, C. Song, G. Anderson, P. Galecki, et al. 2012. Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. BMC Medicine 10: 66.PubMedPubMedCentralCrossRef
39.
40.
Zurück zum Zitat Yu, C.H., J. Moecking, M. Geyer, and S.L. Masters. 2018. Mechanisms of NLRP1-mediated autoinflammatory disease in humans and mice. Journal of Molecular Biology 430: 142–152.PubMedCrossRef Yu, C.H., J. Moecking, M. Geyer, and S.L. Masters. 2018. Mechanisms of NLRP1-mediated autoinflammatory disease in humans and mice. Journal of Molecular Biology 430: 142–152.PubMedCrossRef
41.
Zurück zum Zitat Martinon, F., and J. Tschopp. 2005. NLRs join TLRs as innate sensors of pathogens. Trends in Immunology 26: 447–454.PubMedCrossRef Martinon, F., and J. Tschopp. 2005. NLRs join TLRs as innate sensors of pathogens. Trends in Immunology 26: 447–454.PubMedCrossRef
42.
Zurück zum Zitat Yap, J.K.Y., B.S. Pickard, E.W.L. Chan, and S.Y. Gan. 2019. The role of neuronal NLRP1 inflammasome in Alzheimer’s disease: Bringing neurons into the neuroinflammation game. Molecular Neurobiology 56: 7741–7753.PubMedCrossRef Yap, J.K.Y., B.S. Pickard, E.W.L. Chan, and S.Y. Gan. 2019. The role of neuronal NLRP1 inflammasome in Alzheimer’s disease: Bringing neurons into the neuroinflammation game. Molecular Neurobiology 56: 7741–7753.PubMedCrossRef
43.
Zurück zum Zitat Mawhinney, L.J., J.P.d.V. Rivero, G.A. Dale, R.W. Keane, and H.M. Bramlett. 2011. Heightened inflammasome activation is linked to age-related cognitive impairment in Fischer 344 rats. BMC Neuroscience 12. Mawhinney, L.J., J.P.d.V. Rivero, G.A. Dale, R.W. Keane, and H.M. Bramlett. 2011. Heightened inflammasome activation is linked to age-related cognitive impairment in Fischer 344 rats. BMC Neuroscience 12.
44.
Zurück zum Zitat de Rivero Vaccari, J.P., F. Brand 3rd., S. Adamczak, S.W. Lee, J. Perez-Barcena, M.Y. Wang, et al. 2016. Exosome-mediated inflammasome signaling after central nervous system injury. Journal of Neurochemistry 136 (Suppl 1): 39–48.PubMedCrossRef de Rivero Vaccari, J.P., F. Brand 3rd., S. Adamczak, S.W. Lee, J. Perez-Barcena, M.Y. Wang, et al. 2016. Exosome-mediated inflammasome signaling after central nervous system injury. Journal of Neurochemistry 136 (Suppl 1): 39–48.PubMedCrossRef
45.
Zurück zum Zitat Pontillo, A., E. Catamo, B. Arosio, D. Mari, and S. Crovella. 2012. NALP1/NLRP1 genetic variants are associated with Alzheimer disease. Alzheimer Disease and Associated Disorders 26: 277–281.PubMedCrossRef Pontillo, A., E. Catamo, B. Arosio, D. Mari, and S. Crovella. 2012. NALP1/NLRP1 genetic variants are associated with Alzheimer disease. Alzheimer Disease and Associated Disorders 26: 277–281.PubMedCrossRef
46.
Zurück zum Zitat Fan, J.J., B. Gao, A.Q. Song, Y.J. Zhu, J. Zhou, W.Z. Li, et al. 2020. Spinal cord NLRP1 inflammasome contributes to dry skin induced chronic itch in mice. Journal of Neuroinflammation 17: 122.PubMedPubMedCentralCrossRef Fan, J.J., B. Gao, A.Q. Song, Y.J. Zhu, J. Zhou, W.Z. Li, et al. 2020. Spinal cord NLRP1 inflammasome contributes to dry skin induced chronic itch in mice. Journal of Neuroinflammation 17: 122.PubMedPubMedCentralCrossRef
47.
Zurück zum Zitat Begni, V., M.A. Riva, and A. Cattaneo. 2017. Cellular and molecular mechanisms of the brain-derived neurotrophic factor in physiological and pathological conditions. Clinical Science (London, England) 131: 123–138.CrossRef Begni, V., M.A. Riva, and A. Cattaneo. 2017. Cellular and molecular mechanisms of the brain-derived neurotrophic factor in physiological and pathological conditions. Clinical Science (London, England) 131: 123–138.CrossRef
48.
Zurück zum Zitat Jin. W. 2020. Regulation of BDNF-TrkB signaling and potential therapeutic strategies for Parkinson’s disease. Journal of Clinical Medicine 9. Jin. W. 2020. Regulation of BDNF-TrkB signaling and potential therapeutic strategies for Parkinson’s disease. Journal of Clinical Medicine 9.
49.
50.
Zurück zum Zitat Chan, M.F., J. Li, A. Bertrand, A.J. Casbon, J.H. Lin, I. Maltseva, et al. 2013. Protective effects of matrix metalloproteinase-12 following corneal injury. Journal of Cell Science 126: 3948–3960.PubMedPubMedCentral Chan, M.F., J. Li, A. Bertrand, A.J. Casbon, J.H. Lin, I. Maltseva, et al. 2013. Protective effects of matrix metalloproteinase-12 following corneal injury. Journal of Cell Science 126: 3948–3960.PubMedPubMedCentral
51.
Zurück zum Zitat Giacobbo, B.L., J. Doorduin, H.C. Klein, R. Dierckx, E. Bromberg, and E.F.J. de Vries. 2019. Brain-derived neurotrophic factor in brain disorders: Focus on neuroinflammation. Molecular Neurobiology 56: 3295–3312.CrossRef Giacobbo, B.L., J. Doorduin, H.C. Klein, R. Dierckx, E. Bromberg, and E.F.J. de Vries. 2019. Brain-derived neurotrophic factor in brain disorders: Focus on neuroinflammation. Molecular Neurobiology 56: 3295–3312.CrossRef
52.
Zurück zum Zitat Komulainen, P., M. Pedersen, T. Haenninen, H. Bruunsgaard, T.A. Lakka, M. Kivipelto, et al. 2008. BDNF is a novel marker of cognitive function in ageing women: The DR’s EXTRA Study. Neurobiology of Learning and Memory 90: 596–603.PubMedCrossRef Komulainen, P., M. Pedersen, T. Haenninen, H. Bruunsgaard, T.A. Lakka, M. Kivipelto, et al. 2008. BDNF is a novel marker of cognitive function in ageing women: The DR’s EXTRA Study. Neurobiology of Learning and Memory 90: 596–603.PubMedCrossRef
Metadaten
Titel
Aging Promotes Chronic Stress-Induced Depressive-Like Behavior by Activating NLRP1 Inflammasome-Driven Inflammatory Signaling in Mice
verfasst von
Ya-Jing Zhu
Jun-Juan Fan
Fang-Yi Wu
Ming Zhang
Ao-Qi Song
Yong Li
Yan-Kun Li
Wen-Ning Wu
Publikationsdatum
02.07.2022
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 6/2022
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-022-01683-4

Weitere Artikel der Ausgabe 6/2022

Inflammation 6/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Bei Herzinsuffizienz muss „Eisenmangel“ neu definiert werden!

16.05.2024 Herzinsuffizienz Nachrichten

Bei chronischer Herzinsuffizienz macht es einem internationalen Expertenteam zufolge wenig Sinn, die Diagnose „Eisenmangel“ am Serumferritin festzumachen. Das Team schlägt vor, sich lieber an die Transferrinsättigung zu halten.

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.